Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hutchinson, Kansas, June 20, 2005
In this weeks Investor Update we hope to answer some frequently asked questions that we have had from investors.
1) When will the first order of product from the US manufacturer be in?
HEE Corporation is expecting its first delivery of USA-manufactured HPB-84 in the next few weeks. HEE Corporation will be providing additional information about its weight loss product next week, including arrival, pricing and shipping information.
2) When or how can we find out more about the HPB-Artery Klenz?
HEE Corporation will be bringing a number of breakthrough products, including HPB-Artery Klenz, to market in the coming months. Stay tuned to the weekly updates section for more information on the manufacture and delivery of these additional products. HEE Corporation is committed to successfully marketing and distributing HPB-84 and our new weight loss product. Once the protocol is finalized and test patients are identified then a formal press release will disclose the details.
Albert
NEWS!!!
HEE Corporation's HPB WL2000 Helps Metabolic Syndrome Sufferers Lose Weight
Monday June 20, 9:30 am ET
Herbal Supplement Addresses Nation's Most Prevalent Health Conditions
HUTCHINSON, Kan., June 20 /PRNewswire-FirstCall/ -- HEE Corporation (OTC Bulletin Board: HCCF - News) announced the introduction of HPB-WL2000, a nutraceutical product that can help millions of sufferers of metabolic syndrome, which is recognized by the Centers for Disease Control (CDC) as one of the most prevalent health conditions in the United States. The proprietary blend of ingredients in the herbal supplement is generally recognized by the FDA as safe (GRAS).
"HEE Corporation is committed to improving the quality of life for sufferers of metabolic syndrome before their condition leads to more serious diseases, such as stroke or Type II diabetes," said Radley Brooks, president of HEE Corporation. "Losing weight is often the first step patients can take to improve their health, and WL2000's price point and potency will give them a better chance at succeeding."
Metabolic syndrome is a series of symptoms which include diabetes or pre- diabetes, abdominal obesity, an unfavorable lipid profile and hypertension. According to the International Diabetes Foundation, having metabolic syndrome triples the risk of myocardial infarction or stroke, doubles mortality, and increases the risk of developing Type II diabetes fivefold.
Metabolic syndrome affects 44 percent of people 50 years and older, according to the CDC. About 40 percent of adults ages 40 to 74 -- or 41 million people -- have pre-diabetes. Studies show that losing a small amount of weight and increasing physical activity is especially effective in reducing the risk of developing full-blown Type II diabetes among this age group. A person can be tested for metabolic syndrome using measurements of waist circumference, concentrations of triglycerides, high-density lipoprotein (HDL) cholesterol (the "good cholesterol"), fasting blood glucose levels, and elevated blood pressure.
Unlike many weight loss products that mask symptoms, HEE Corporation's blend of herbal ingredients addresses the causes of weight gain by helping to:
-- Reduce the formation of fatty tissue
-- Reduce the conversion of simple sugars
-- Promote healthy energy levels
-- Normalize food cravings
-- Suppress appetite
-- Increase metabolism
-- Help maintain a normal cholesterol level
-- Speed recovery from fatigue
To ensure the quality and efficacy of the proprietary formula, the manufacture of HPB-WL2000 meets the National Nutritional Foods Association's (NNFA) proposed guidelines for good manufacturing practices (GMP).
HPB-WL2000 will be sold exclusively through HEE Corporation's Web site at http://www.hee-corp.com and a 30-day supply will retail for $59.95.
Einde jaar 030
The news becomes always improves, only sale figures is lacking still rate nevertheless higher must stand, but nobody knows the share therefore advertisement to make and rapidly.
Albert
NEWS!!!
HEE Corporation's HPB WL2000 Helps Metabolic Syndrome Sufferers Lose Weight
Monday June 20, 9:30 am ET
Herbal Supplement Addresses Nation's Most Prevalent Health Conditions
HUTCHINSON, Kan., June 20 /PRNewswire-FirstCall/ -- HEE Corporation (OTC Bulletin Board: HCCF - News) announced the introduction of HPB-WL2000, a nutraceutical product that can help millions of sufferers of metabolic syndrome, which is recognized by the Centers for Disease Control (CDC) as one of the most prevalent health conditions in the United States. The proprietary blend of ingredients in the herbal supplement is generally recognized by the FDA as safe (GRAS).
"HEE Corporation is committed to improving the quality of life for sufferers of metabolic syndrome before their condition leads to more serious diseases, such as stroke or Type II diabetes," said Radley Brooks, president of HEE Corporation. "Losing weight is often the first step patients can take to improve their health, and WL2000's price point and potency will give them a better chance at succeeding."
Metabolic syndrome is a series of symptoms which include diabetes or pre- diabetes, abdominal obesity, an unfavorable lipid profile and hypertension. According to the International Diabetes Foundation, having metabolic syndrome triples the risk of myocardial infarction or stroke, doubles mortality, and increases the risk of developing Type II diabetes fivefold.
Metabolic syndrome affects 44 percent of people 50 years and older, according to the CDC. About 40 percent of adults ages 40 to 74 -- or 41 million people -- have pre-diabetes. Studies show that losing a small amount of weight and increasing physical activity is especially effective in reducing the risk of developing full-blown Type II diabetes among this age group. A person can be tested for metabolic syndrome using measurements of waist circumference, concentrations of triglycerides, high-density lipoprotein (HDL) cholesterol (the "good cholesterol"), fasting blood glucose levels, and elevated blood pressure.
Unlike many weight loss products that mask symptoms, HEE Corporation's blend of herbal ingredients addresses the causes of weight gain by helping to:
-- Reduce the formation of fatty tissue
-- Reduce the conversion of simple sugars
-- Promote healthy energy levels
-- Normalize food cravings
-- Suppress appetite
-- Increase metabolism
-- Help maintain a normal cholesterol level
-- Speed recovery from fatigue
To ensure the quality and efficacy of the proprietary formula, the manufacture of HPB-WL2000 meets the National Nutritional Foods Association's (NNFA) proposed guidelines for good manufacturing practices (GMP).
HPB-WL2000 will be sold exclusively through HEE Corporation's Web site at http://www.hee-corp.com and a 30-day supply will retail for $59.95.
Albert BUY BUY
NEWS!!!
HEE Corporation's HPB WL2000 Helps Metabolic Syndrome Sufferers Lose Weight
Monday June 20, 9:30 am ET
Herbal Supplement Addresses Nation's Most Prevalent Health Conditions
HUTCHINSON, Kan., June 20 /PRNewswire-FirstCall/ -- HEE Corporation (OTC Bulletin Board: HCCF - News) announced the introduction of HPB-WL2000, a nutraceutical product that can help millions of sufferers of metabolic syndrome, which is recognized by the Centers for Disease Control (CDC) as one of the most prevalent health conditions in the United States. The proprietary blend of ingredients in the herbal supplement is generally recognized by the FDA as safe (GRAS).
"HEE Corporation is committed to improving the quality of life for sufferers of metabolic syndrome before their condition leads to more serious diseases, such as stroke or Type II diabetes," said Radley Brooks, president of HEE Corporation. "Losing weight is often the first step patients can take to improve their health, and WL2000's price point and potency will give them a better chance at succeeding."
Metabolic syndrome is a series of symptoms which include diabetes or pre- diabetes, abdominal obesity, an unfavorable lipid profile and hypertension. According to the International Diabetes Foundation, having metabolic syndrome triples the risk of myocardial infarction or stroke, doubles mortality, and increases the risk of developing Type II diabetes fivefold.
Metabolic syndrome affects 44 percent of people 50 years and older, according to the CDC. About 40 percent of adults ages 40 to 74 -- or 41 million people -- have pre-diabetes. Studies show that losing a small amount of weight and increasing physical activity is especially effective in reducing the risk of developing full-blown Type II diabetes among this age group. A person can be tested for metabolic syndrome using measurements of waist circumference, concentrations of triglycerides, high-density lipoprotein (HDL) cholesterol (the "good cholesterol"), fasting blood glucose levels, and elevated blood pressure.
Unlike many weight loss products that mask symptoms, HEE Corporation's blend of herbal ingredients addresses the causes of weight gain by helping to:
-- Reduce the formation of fatty tissue
-- Reduce the conversion of simple sugars
-- Promote healthy energy levels
-- Normalize food cravings
-- Suppress appetite
-- Increase metabolism
-- Help maintain a normal cholesterol level
-- Speed recovery from fatigue
To ensure the quality and efficacy of the proprietary formula, the manufacture of HPB-WL2000 meets the National Nutritional Foods Association's (NNFA) proposed guidelines for good manufacturing practices (GMP).
HPB-WL2000 will be sold exclusively through HEE Corporation's Web site at http://www.hee-corp.com and a 30-day supply will retail for $59.95.
Albert BUY BUY
Yes that is correct. This is not a profile, but a stock pick under a penny that had a 52 week high over $1.HCCF just launched a new site http://biz.yahoo.com/prnews/050422/cgf040.html?.v=4 HEE Corporation) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the web site marks the first time HPB-84 has been available for sale to the public.
The HEE Corporation
The HEE Corporation (OTCPK:HCCF) is a publicly traded company that was founded for the purpose of providing a corporate vehicle for marketing a new and extremely promising nutriceutical for Type II Diabetes. This nutriceutical was developed and tested in India . HEE Corp has the world-wide rights (exclusive of India ) and is currently bringing it to the market in the United States and Internationally. Based upon the highly successful results of the product in India , and the testimonials from those who have taken it here in the USA, HEE Corp is very excited about what we can do with the product world-wide.
Type II Diabetes has reached epidemic levels in The United States with 18.2 million confirmed cases and an estimated 5 million (nearly one-third of that total) not yet aware that they have Diabetes! Diabetes is the fifth leading cause of death by disease in the U.S.
Diabetes is now a modern-day epidemic, with some 171,000,000 people around the globe are estimated to have diabetes and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Type II Diabetes is the cause of many other ailments including heart disease, renal failure, blindness, skin problems and even loss of limbs. While there are treatments available for Diabetes they are often focused on treating the symptoms and not on eradicating the actual disease. Many of the side effects of prescription drugs for diabetes are uncomfortable for the patient and even dangerous.
While this is a relatively new product here in the USA , the promise of this revolutionary product cannot be ignored. While nutriceutical treatments have not received a huge following in the United States they have large followings in the rest of the world. HEE might not change medical history, but our product certainly does have a positive effect on those people who suffer from Type II Diabetes.
Please be aware that this stock trades in 20-30% ranges during the day. We have been adding to our position under .01.The nutriceutical arena will be hot this year.We own a large position bought in the open market and can sell at any time.
1 Year price target : .30 Cents
This Is a PR that HCCF came out with today. http://biz.yahoo.com/prnews/050503/cgtu041.html?.v=9
Read The last paragraph:
Wil graag informatie over HTB84 pil tegen diabetes
biohf can make 100 contracts with cosco, but nothing helps....
after 11 years of leis company does not have credebility.... SEL SEL verkopen niks waard
hshl SEL
Hee Corp. (OTC: HCCF)
17-06-2005 Close .0.007
Yes that is correct. This is not a profile, but a stock pick under a penny that had a 52 week high over $1.HCCF just launched a new site http://biz.yahoo.com/prnews/050422/cgf040.html?.v=4 HEE Corporation) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the web site marks the first time HPB-84 has been available for sale to the public.
The HEE Corporation
The HEE Corporation (OTCPK:HCCF) is a publicly traded company that was founded for the purpose of providing a corporate vehicle for marketing a new and extremely promising nutriceutical for Type II Diabetes. This nutriceutical was developed and tested in India . HEE Corp has the world-wide rights (exclusive of India ) and is currently bringing it to the market in the United States and Internationally. Based upon the highly successful results of the product in India , and the testimonials from those who have taken it here in the USA, HEE Corp is very excited about what we can do with the product world-wide.
Type II Diabetes has reached epidemic levels in The United States with 18.2 million confirmed cases and an estimated 5 million (nearly one-third of that total) not yet aware that they have Diabetes! Diabetes is the fifth leading cause of death by disease in the U.S.
Diabetes is now a modern-day epidemic, with some 171,000,000 people around the globe are estimated to have diabetes and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Type II Diabetes is the cause of many other ailments including heart disease, renal failure, blindness, skin problems and even loss of limbs. While there are treatments available for Diabetes they are often focused on treating the symptoms and not on eradicating the actual disease. Many of the side effects of prescription drugs for diabetes are uncomfortable for the patient and even dangerous.
While this is a relatively new product here in the USA , the promise of this revolutionary product cannot be ignored. While nutriceutical treatments have not received a huge following in the United States they have large followings in the rest of the world. HEE might not change medical history, but our product certainly does have a positive effect on those people who suffer from Type II Diabetes.
Please be aware that this stock trades in 20-30% ranges during the day. We have been adding to our position under .01.The nutriceutical arena will be hot this year.We own a large position bought in the open market and can sell at any time.
1 Year price target : .30 Cents
This Is a PR that HCCF came out with today. http://biz.yahoo.com/prnews/050503/cgtu041.html?.v=9
Read The last paragraph:
The Board's formation comes at a time when consumer recognition of HEE Corporation and HPB-84 is quickly growing. Over a four-day period last week, (Friday 4-22-05 afternoon through Tuesday 4-26-05), the company's corporate website received 174,000 hits in response to its announcement of HPB-84's availability.
This pick will go to the free list Wed night. We feel this could be our top % gainer of the year.
fair disclosure: We own a position in hccf.
Hee Corp. (OTC: HCCF)
17-06-2005 Close .0.007
Yes that is correct. This is not a profile, but a stock pick under a penny that had a 52 week high over $1.HCCF just launched a new site http://biz.yahoo.com/prnews/050422/cgf040.html?.v=4 HEE Corporation) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the web site marks the first time HPB-84 has been available for sale to the public.
The HEE Corporation
The HEE Corporation (OTCPK:HCCF) is a publicly traded company that was founded for the purpose of providing a corporate vehicle for marketing a new and extremely promising nutriceutical for Type II Diabetes. This nutriceutical was developed and tested in India . HEE Corp has the world-wide rights (exclusive of India ) and is currently bringing it to the market in the United States and Internationally. Based upon the highly successful results of the product in India , and the testimonials from those who have taken it here in the USA, HEE Corp is very excited about what we can do with the product world-wide.
Type II Diabetes has reached epidemic levels in The United States with 18.2 million confirmed cases and an estimated 5 million (nearly one-third of that total) not yet aware that they have Diabetes! Diabetes is the fifth leading cause of death by disease in the U.S.
Diabetes is now a modern-day epidemic, with some 171,000,000 people around the globe are estimated to have diabetes and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Type II Diabetes is the cause of many other ailments including heart disease, renal failure, blindness, skin problems and even loss of limbs. While there are treatments available for Diabetes they are often focused on treating the symptoms and not on eradicating the actual disease. Many of the side effects of prescription drugs for diabetes are uncomfortable for the patient and even dangerous.
While this is a relatively new product here in the USA , the promise of this revolutionary product cannot be ignored. While nutriceutical treatments have not received a huge following in the United States they have large followings in the rest of the world. HEE might not change medical history, but our product certainly does have a positive effect on those people who suffer from Type II Diabetes.
Please be aware that this stock trades in 20-30% ranges during the day. We have been adding to our position under .01.The nutriceutical arena will be hot this year.We own a large position bought in the open market and can sell at any time.
1 Year price target : .30 Cents
This Is a PR that HCCF came out with today. http://biz.yahoo.com/prnews/050503/cgtu041.html?.v=9
Read The last paragraph:
The Board's formation comes at a time when consumer recognition of HEE Corporation and HPB-84 is quickly growing. Over a four-day period last week, (Friday 4-22-05 afternoon through Tuesday 4-26-05), the company's corporate website received 174,000 hits in response to its announcement of HPB-84's availability.
This pick will go to the free list Wed night. We feel this could be our top % gainer of the year.
fair disclosure: We own a position in hccf.
OTCF HCCF This product is to the invention of the century tests of this product indicates it. We in the Netherlands say end to this share year 030 pennies
OTCF HCCF This product is to the invention of the century tests of this product indicates it. We in the Netherlands say end to this share year 030 pennies
Hee Corp. (OTC: HCCF)
Yes that is correct. This is not a profile, but a stock pick under a penny that had a 52 week high over $1.HCCF just launched a new site http://biz.yahoo.com/prnews/050422/cgf040.html?.v=4 HEE Corporation) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the web site marks the first time HPB-84 has been available for sale to the public.
The HEE Corporation
The HEE Corporation (OTCPK:HCCF) is a publicly traded company that was founded for the purpose of providing a corporate vehicle for marketing a new and extremely promising nutriceutical for Type II Diabetes. This nutriceutical was developed and tested in India . HEE Corp has the world-wide rights (exclusive of India ) and is currently bringing it to the market in the United States and Internationally. Based upon the highly successful results of the product in India , and the testimonials from those who have taken it here in the USA, HEE Corp is very excited about what we can do with the product world-wide.
Type II Diabetes has reached epidemic levels in The United States with 18.2 million confirmed cases and an estimated 5 million (nearly one-third of that total) not yet aware that they have Diabetes! Diabetes is the fifth leading cause of death by disease in the U.S.
Diabetes is now a modern-day epidemic, with some 171,000,000 people around the globe are estimated to have diabetes and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Type II Diabetes is the cause of many other ailments including heart disease, renal failure, blindness, skin problems and even loss of limbs. While there are treatments available for Diabetes they are often focused on treating the symptoms and not on eradicating the actual disease. Many of the side effects of prescription drugs for diabetes are uncomfortable for the patient and even dangerous.
While this is a relatively new product here in the USA , the promise of this revolutionary product cannot be ignored. While nutriceutical treatments have not received a huge following in the United States they have large followings in the rest of the world. HEE might not change medical history, but our product certainly does have a positive effect on those people who suffer from Type II Diabetes.
Please be aware that this stock trades in 20-30% ranges during the day. We have been adding to our position under .01.The nutriceutical arena will be hot this year.We own a large position bought in the open market and can sell at any time.
1 Year price target : .30 Cents
This Is a PR that HCCF came out with today. http://biz.yahoo.com/prnews/050503/cgtu041.html?.v=9
Read The last paragraph:
The Board's formation comes at a time when consumer recognition of HEE Corporation and HPB-84 is quickly growing. Over a four-day period last week, (Friday 4-22-05 afternoon through Tuesday 4-26-05), the company's corporate website received 174,000 hits in response to its announcement of HPB-84's availability.
This pick will go to the free list Wed night. We feel this could be our top % gainer of the year.
fair disclosure: We own a position in hccf.
BUY BUY
Wil graag informatie over HTB84 pil tegen diabe
Hee Corp. (OTC: HCCF)
5/2/05 Close .008 Cents
Yes that is correct. This is not a profile, but a stock pick under a penny that had a 52 week high over $1.HCCF just launched a new site http://biz.yahoo.com/prnews/050422/cgf040.html?.v=4 HEE Corporation) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the web site marks the first time HPB-84 has been available for sale to the public.
The HEE Corporation
The HEE Corporation (OTCPK:HCCF) is a publicly traded company that was founded for the purpose of providing a corporate vehicle for marketing a new and extremely promising nutriceutical for Type II Diabetes. This nutriceutical was developed and tested in India . HEE Corp has the world-wide rights (exclusive of India ) and is currently bringing it to the market in the United States and Internationally. Based upon the highly successful results of the product in India , and the testimonials from those who have taken it here in the USA, HEE Corp is very excited about what we can do with the product world-wide.
Type II Diabetes has reached epidemic levels in The United States with 18.2 million confirmed cases and an estimated 5 million (nearly one-third of that total) not yet aware that they have Diabetes! Diabetes is the fifth leading cause of death by disease in the U.S.
Diabetes is now a modern-day epidemic, with some 171,000,000 people around the globe are estimated to have diabetes and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Type II Diabetes is the cause of many other ailments including heart disease, renal failure, blindness, skin problems and even loss of limbs. While there are treatments available for Diabetes they are often focused on treating the symptoms and not on eradicating the actual disease. Many of the side effects of prescription drugs for diabetes are uncomfortable for the patient and even dangerous.
While this is a relatively new product here in the USA , the promise of this revolutionary product cannot be ignored. While nutriceutical treatments have not received a huge following in the United States they have large followings in the rest of the world. HEE might not change medical history, but our product certainly does have a positive effect on those people who suffer from Type II Diabetes.
Please be aware that this stock trades in 20-30% ranges during the day. We have been adding to our position under .01.The nutriceutical arena will be hot this year.We own a large position bought in the open market and can sell at any time.
1 Year price target : .30 Cents
This Is a PR that HCCF came out with today. http://biz.yahoo.com/prnews/050503/cgtu041.html?.v=9
Read The last paragraph:
The Board's formation comes at a time when consumer recognition of HEE Corporation and HPB-84 is quickly growing. Over a four-day period last week, (Friday 4-22-05 afternoon through Tuesday 4-26-05), the company's corporate website received 174,000 hits in response to its announcement of HPB-84's availability.
This pick will go to the free list Wed night. We feel this could be our top % gainer of the year.
fair disclosure: We own a position in hccf.
BUY BUY
Darci wrote:
Dear Dr. Haith:HCCF HCCF
Thank you for your inquiry.
HEE Corporation is scheduled to release additional financial information on or about July 15, 2005. Any release of information prior to that date to any investor, or group of investors, would be regarded as the untimely release of “insider information.” Accordingly, we are unable to reply to your request.
However, one item you should note as it is a matter of public record, is HEE Corporation represented a name change from the Goldberg Report, Inc.
Kind regards,
Darci Brooks
Darci wrote:
Dear Dr. Haith:HCCF HCCF
Thank you for your inquiry.
HEE Corporation is scheduled to release additional financial information on or about July 15, 2005. Any release of information prior to that date to any investor, or group of investors, would be regarded as the untimely release of “insider information.” Accordingly, we are unable to reply to your request.
However, one item you should note as it is a matter of public record, is HEE Corporation represented a name change from the Goldberg Report, Inc.
Kind regards,
Darci Brooks
Based on 10000 patients,10 bottles/year,$500/year.HCCF HCCF
If HPB84 Really works,and we get 100'000 patient out of 19mil in US alone (0.5%)not to mention China and Mexico,our future targets)= thats $50 mil annual revenues.
= $1.65/Share!!$3.00 2007 BUY BUY BUY BUYYYYYYYY
The new ASNi.TV website is up and running... 10k filed today.
just go to http://www.asni.tv
This should give everyone a good idea of what is happening over at ASNI...
BUY BUY
The new ASNi.TV website is up and running... 10k filed today.
just go to http://www.asni.tv
This should give everyone a good idea of what is happening over at ASNI...
Darci wrote:
Dear Dr. Haith:
Thank you for your inquiry.
HEE Corporation is scheduled to release additional financial information on or about July 15, 2005. Any release of information prior to that date to any investor, or group of investors, would be regarded as the untimely release of “insider information.” Accordingly, we are unable to reply to your request.
However, one item you should note as it is a matter of public record, is HEE Corporation represented a name change from the Goldberg Report, Inc.
Kind regards,
Darci Brooks
HEE Corporation (HCCF.PK)
Investor Relations
(620)663-3333
BUY BUY BUY
Based on 10000 patients,10 bottles/year,$500/year.
If HPB84 Really works,and we get 100'000 patient out of 19mil in US alone (0.5%)not to mention China and Mexico,our future targets)= thats $50 mil annual revenues.
= $1.65/Share!! HCCF BUY BUY
Based on 10000 patients,10 bottles/year,$500/year.
If HPB84 Really works,and we get 100'000 patient out of 19mil in US alone (0.5%)not to mention China and Mexico,our future targets)= thats $50 mil annual revenues.
= $1.65/Share!! HCCF HCCF BUY BUY 032 jan 2006
If HPB84 Really works,and we get 100'000 patient out of 19mil in US alone (0.5%)not to mention China and Mexico,our future targets)= thats $50 mil annual revenues.
= $1.65/Share!!
HSHL Sel Sel
Deep and I suspect as low as 2.00/sh, but this is a company on the move. Earnings from other enterprises they have are due soon; yesterday, it was NASA news. I wouldn't be surprised that Huff will soon announce the Strat has been reassembled and undergoing a new round of testing. Post R/S stocks are known for selling off to pre-split levels. Not likely with GTE, in fact, I suspect 2.00 may not be possible. Don't let it go more than 5 weeks or so as I suspect the share price may fatten up in advance of the launch later this summer/early fall. A serious board for GTE is: HCCF BUY
Deep and I suspect as low as 2.00/sh, but this is a company on the move. Earnings from other enterprises they have are due soon; yesterday, it was NASA news. I wouldn't be surprised that Huff will soon announce the Strat has been reassembled and undergoing a new round of testing. Post R/S stocks are known for selling off to pre-split levels. Not likely with GTE, in fact, I suspect 2.00 may not be possible. Don't let it go more than 5 weeks or so as I suspect the share price may fatten up in advance of the launch later this summer/early fall. A serious board for GTE is: INVESTORSHUB/GTE/
ASNI KOOP BUY
investor in this company, but a huge backer of Hee Corp. They are blessed with a board full of honest and good people, that really believe in them and their ability to get this company "on the map". Inadvertantly, we all are giving this company great press every day that we post. To see the total of shares owned by these posters is amazing. If the company would step up to the plate and purchase a nice sized block of shares, they would put every market maker in this stock on notice, that this is a pretty powerful group that supports HCCF. NOT ONLY WOULD THIS SEND THEM A STRONG MESSAGE, NOT TO PLAY AROUND BY SHORTING THIS STOCK, BUT IT WOULD ALSO GIVE CURRENT AND POSSIBLY SOME NEW SHARE HOLDERS A REASON TO BUY SHARES
HCCF BUY
investor in this company, but a huge backer of Hee Corp. They are blessed with a board full of honest and good people, that really believe in them and their ability to get this company "on the map". Inadvertantly, we all are giving this company great press every day that we post. To see the total of shares owned by these posters is amazing. If the company would step up to the plate and purchase a nice sized block of shares, they would put every market maker in this stock on notice, that this is a pretty powerful group that supports HCCF. NOT ONLY WOULD THIS SEND THEM A STRONG MESSAGE, NOT TO PLAY AROUND BY SHORTING THIS STOCK, BUT IT WOULD ALSO GIVE CURRENT AND POSSIBLY SOME NEW SHARE HOLDERS A REASON TO BUY SHARES
HCCF
Based on 10000 patients,10 bottles/year,$500/year.hccf
If HPB84 Really works,and we get 100'000 patient out of 19mil in US alone (0.5%)not to mention China and Mexico,our future targets)= thats $50 mil annual revenues.
= $1.65/Share!!
Penny stocks are a gamble,they go up on hype and unfortunitly most fail.Very seldom do you run across a stock such as Gte,when I first bought it it traded under Adgi at .025 and the strats were unheard of,got very lucky on this one.
As far as HCCF is concerned I too have type 2 and would love to get off the pills I have to take three times a day.
This along wih the price is why I invested in this one.
I currently own a very large interest in GTE becouse I added over the years and have doubled my position in HCCF and hope for anouther home run,but know the time if things go not progress to do so.
Not a flipper ,don't have time do do that. Watch every move that this company makes and see if you have a good feeling
about their progress.This could be a big winner if the product works and they have the funds to market it.GTE had to sell millions of shares just to stay alive back in the old days,if HCCF does the same thing make sure the sales are not to line the pockets of directors.
Good Luck to all
Copperbird BUY BUY BUY
HCCF/ASNI BUYYYYYYYYY
HCCF Buy Buy 0.009
Darci wrote:
Dear Dr. Haith:
Thank you for your inquiry.
HEE Corporation is scheduled to release additional financial information on or about July 15, 2005. Any release of information prior to that date to any investor, or group of investors, would be regarded as the untimely release of “insider information.” Accordingly, we are unable to reply to your request.
However, one item you should note as it is a matter of public record, is HEE Corporation represented a name change from the Goldberg Report, Inc.
Kind regards,
Darci Brooks
HEE Corporation (HCCF.PK)
Investor Relations
(620)663-3333
Darci wrote:
Dear Dr. Haith:
Thank you for your inquiry.
HEE Corporation is scheduled to release additional financial information on or about July 15, 2005. Any release of information prior to that date to any investor, or group of investors, would be regarded as the untimely release of “insider information.” Accordingly, we are unable to reply to your request.
However, one item you should note as it is a matter of public record, is HEE Corporation represented a name change from the Goldberg Report, Inc.
Kind regards,
Darci Brooks
HEE Corporation (HCCF.PK)
Investor Relations
(620)663-3333
- - - - -
HCCF BUY BUY 0.009
ASNI ASNI BUY BUY
RESULTS OF OPERATION.
During fiscal year-ending February 28,2005, the company incurred a loss of ($292,529) compared to a loss of ($418,905) for the prior year. The Company had revenues of $4,700 for 2005 and $15,000 for 2004. Costs and expenses were $241,787 for 2005 and $385,149 for 2004. Loss per share of $(0.011) for 2005 and $(0.017) for 2004. The decrease is primarily due to having an increase in the amount of shares outstanding.
The Company's library of shows and developed projects are the principal assets of the Registrant. The Registrant had produced and aired "Masters of the Martial Arts" a weekly series that aired for two years on ICN (International Channel Network). The previous and other shows developed and produced by the company are currently not airing or generating income.
Registrant has sustained operations with limited revenues during a period that's been devoted primarily to design, development, and packaging of its anticipated productions. The Registrant has created the primary marketing tools supported by websites and advertising campaigns for the upcoming infomercial "Intervention". Management has developed relationships with various media buyers and public relations firms to distribute its shows and has secured vendors to supply various products to be used as added value in the marketing of its infomercials and television shows.
There was no Federal Tax expense for the year ended February 28,2005. The Registrant has a tax loss benefit to carry-forward of approximately $2,900,000 which is available to offset future tax liabilities.
LIQUIDITY AND CAPITAL RESOURCES
For the fiscal year ended February 28,2005 cash flow came from the issuance of common stock ($18,000) and from advances from shareholders. Cash expended on operating expenses was $241,787.
.
The Company has devoted significant time, effort and resources to obtain private funding to fund the development, production and distribution of our infomercials and television programs. Assuming that expenses remain at the current level, additional cash will be required to complete production and air existing projects in place. The Company will require approximately $1,000,000 of additional operating capital during the fiscal year ending February 28, 2006. The Company intends to secure funds with the release of a private placement; but, it is uncertain whether the required financing will be secured under favorable terms.
BUY BUY BUY
None
RISK FACTORS
The Company's business is subject to numerous risk factors, not all of which can be known or anticipated and any one of which could adversely impact the Company or its financial condition. Risk Factors include:
Failure to License: Renew Licenses or Production Agreements
HEE Corporation's Breakthrough Supplement, HPB-84, Manufactured According to GMP Guidelines
Tuesday June 14, 8:30 am ET
Regional Manufacturing Allows for Greater Quality Assurance and Tighter Quality Control
HUTCHINSON, Kan., June 14 /PRNewswire-FirstCall/ -- HEE Corporation announced today that its breakthrough herbal supplement for Type II Diabetes, HPB-84, is manufactured in the United States according to the National Nutritional Foods Association's (NNFA) proposed guidelines for good manufacturing practices (GMP).
ADVERTISEMENT
"By manufacturing HEE Corporation's current and future products under the highest standards of nutritional foods manufacturing, our customers can be assured of the quality, potency and efficacy of our products," said Radley Brooks, President of HEE Corporation.
According to the NNFA and HEE Corporation guidelines, the manufacture of HPB-84 must meet or exceed high standards. Every element of the manufacturing process is evaluated, including personnel, operating procedures, raw material testing, batch production, quality control, label control, sanitation and analytical laboratory capabilities. For instance, raw material is pre-tested to verify purity and potency, and quality records ensure formulations meet label claims. In addition, an in-house quality control unit has final approval on procedures, specifications, purity, finished product, product labeling, product formulations and production records.
"These standards are extremely important to our customers," said Brooks. "The technical details aren't of interest to most, but our customers appreciate the fact that HPB-84 is inspected up to 16 different times before it is shipped to them."
HEE Corp. developed the breakthrough nutraceutical, HPB-84, which safely and effectively addresses the causes of Type II diabetes. For sufferers of Type II diabetes, HPB-84 addresses three major issues: reducing blood sugar levels, insulin resistance and promoting insulin production.
About HEE Corporation
Founded in Hutchinson, Kansas in December 2003, HEE Corporation (OTCPK: HCCF) is a publicly-traded company committed to improving the quality of life through the research, development and distribution of products, services and nutraceuticals that address many of the causes of metabolic syndrome. Metabolic syndrome is quickly being recognized by the medical community as one of the most prevalent health conditions in the United States. HPB-84, manufactured in the United States, is currently sold exclusively through http://www.hpb84.net . It contains a proprietary blend of the following ingredients generally recognized by the FDA as safe (GRAS). Complete company and investor information can be found at the company Web site, http://www.hee-corp.com.
Albert BUY BUY BUY
CNES SEL SEL 0.00001